DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

160.59 -0.21 (-0.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $160.59 -0.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $161.28
Previous Close $160.80
Daily Range $160.25 - $162.80
52-Week Range $106.00 - $162.80
Market Cap $53.9B
P/E Ratio 104.42
Dividend (Yield) $0.00 (0.0%)
Volume 2,141,402
Average Daily Volume 2,029,190
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

3 Stocks Boosting The Drugs Industry Higher

New Guru Jana Partners' Newest Stock Buys

A Look At Actavis

Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog

Why Valeant Pharmaceuticals (VRX) Isn't Done Growing Earnings Yet - Tale of the Tape

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formular

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formulary Concerns Are Noise

Valeant CEO On Allegations Against The Company And Future M&A Deals

New Lifetime High Today: Valeant Pharmaceuticals International (VRX)

Valeant Pharmaceuticals, A Bet The Jockey Story With Upside

Analysts Make Bullish Ratings in Response to Valeant's Increased 2015 Guidance

See More VRX News...

VRX's Top Competitors

VRX $160.59 (-0.13%)
Current stock: VRX
JNJ $101.48 (-0.60%)
Current stock: JNJ
PFE $31.95 (-1.99%)
Current stock: PFE
RHHBY $34.47 (-3.45%)
Current stock: RHHBY